| Post |
| Pre |
| LA |
|---|
| - |
| - |
| ME 1 | ME 2 | ME 3 | ME 4 | ME 5 | ME 6 | ME 7 | ME 8 | ME 9 | ME 10 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | 0 |
| - | - | - | - | - | - | - | 4 | 3 | 2 | 9 |
| Post |
| Pre |
| LO 1 | LO 2 | LO 3 | LO 4 | LO 5A | LO 5B | LO 6 | Total |
|---|---|---|---|---|---|---|---|
| 5 | 71 | - | - | - | - | - | 76 |
| - | 3 | - | - | - | - | - | 3 |
| AME |
|---|
| - |
| - |
| Post |
| Pre |
| LOP 1 | LOP 2 | LOP 3 | LOP 4 | Total |
|---|---|---|---|---|
| 1 | 9 | 1 | - | 11 |
| - | 11 | - | - | 11 |
| central brain |
|---|
| - |
| - |

| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| LO(R) | 76 | 85.4% | -4.66 | 3 | 10.7% |
| LOP(R) | 11 | 12.4% | 0.00 | 11 | 39.3% |
| ME(R) | 0 | 0.0% | inf | 9 | 32.1% |
| Optic-unspecified(R) | 2 | 2.2% | 1.32 | 5 | 17.9% |
| upstream partner | # | NT | conns T5a_unclear | % In | CV |
|---|---|---|---|---|---|
| CT1 (L) | 1 | GABA | 18 | 20.7% | 0.0 |
| Tm9 (R) | 5 | ACh | 18 | 20.7% | 0.5 |
| Tm2 (R) | 4 | ACh | 16 | 18.4% | 0.5 |
| Tm1 (R) | 4 | ACh | 12 | 13.8% | 0.4 |
| Y11 (R) | 1 | Glu | 3 | 3.4% | 0.0 |
| TmY15 (R) | 1 | GABA | 3 | 3.4% | 0.0 |
| LPi21 (R) | 1 | GABA | 3 | 3.4% | 0.0 |
| Tm4 (R) | 2 | ACh | 3 | 3.4% | 0.3 |
| Li25 (R) | 1 | GABA | 2 | 2.3% | 0.0 |
| LPi2c (R) | 1 | Glu | 2 | 2.3% | 0.0 |
| T5d (R) | 1 | ACh | 1 | 1.1% | 0.0 |
| T5c (R) | 1 | ACh | 1 | 1.1% | 0.0 |
| C3 (R) | 1 | GABA | 1 | 1.1% | 0.0 |
| Tm37 (R) | 1 | Glu | 1 | 1.1% | 0.0 |
| Tlp11 (R) | 1 | Glu | 1 | 1.1% | 0.0 |
| LPT114 (R) | 1 | GABA | 1 | 1.1% | 0.0 |
| DCH (L) | 1 | GABA | 1 | 1.1% | 0.0 |
| downstream partner | # | NT | conns T5a_unclear | % Out | CV |
|---|---|---|---|---|---|
| TmY21 (R) | 6 | ACh | 12 | 11.2% | 0.6 |
| TmY16 (R) | 1 | Glu | 8 | 7.5% | 0.0 |
| LLPC1 (R) | 1 | ACh | 6 | 5.6% | 0.0 |
| DCH (L) | 1 | GABA | 6 | 5.6% | 0.0 |
| TmY9b (R) | 2 | ACh | 6 | 5.6% | 0.7 |
| MeLo1 (R) | 1 | ACh | 5 | 4.7% | 0.0 |
| Y11 (R) | 1 | Glu | 5 | 4.7% | 0.0 |
| Y3 (R) | 3 | ACh | 5 | 4.7% | 0.3 |
| T2 (R) | 1 | ACh | 4 | 3.7% | 0.0 |
| TmY14 (R) | 1 | unc | 4 | 3.7% | 0.0 |
| Cm19 (R) | 1 | GABA | 4 | 3.7% | 0.0 |
| LPi12 (R) | 1 | GABA | 4 | 3.7% | 0.0 |
| Mi9 (R) | 2 | Glu | 4 | 3.7% | 0.0 |
| T4a (R) | 3 | ACh | 4 | 3.7% | 0.4 |
| TmY9a (R) | 1 | ACh | 3 | 2.8% | 0.0 |
| Mi1 (R) | 1 | ACh | 3 | 2.8% | 0.0 |
| MeLo9 (R) | 1 | Glu | 3 | 2.8% | 0.0 |
| Tm20 (R) | 1 | ACh | 2 | 1.9% | 0.0 |
| C3 (R) | 1 | GABA | 2 | 1.9% | 0.0 |
| Tlp11 (R) | 1 | Glu | 2 | 1.9% | 0.0 |
| MeLo8 (R) | 1 | GABA | 2 | 1.9% | 0.0 |
| Tm9 (R) | 2 | ACh | 2 | 1.9% | 0.0 |
| T5b (R) | 2 | ACh | 2 | 1.9% | 0.0 |
| LC14b (L) | 1 | ACh | 1 | 0.9% | 0.0 |
| LT33 (L) | 1 | GABA | 1 | 0.9% | 0.0 |
| Mi2 (R) | 1 | Glu | 1 | 0.9% | 0.0 |
| T5c (R) | 1 | ACh | 1 | 0.9% | 0.0 |
| Mi4 (R) | 1 | GABA | 1 | 0.9% | 0.0 |
| TmY5a (R) | 1 | Glu | 1 | 0.9% | 0.0 |
| Li25 (R) | 1 | GABA | 1 | 0.9% | 0.0 |
| Pm4 (R) | 1 | GABA | 1 | 0.9% | 0.0 |
| CT1 (L) | 1 | GABA | 1 | 0.9% | 0.0 |